TCG Crossover

TCG Crossover is a science-driven venture capital firm investing from closed-end funds in innovative biotech companies and transformative medicines. The firm focuses on later-stage venture opportunities in biotechnology, life sciences, and pharmaceuticals, backs companies across the United States, China, and Europe, and has acted as a co-lead investor in financing rounds. Based in Palo Alto, it offers patient capital and support around scientific diligence, capital markets, and geographic expansion.